Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
42,998,448
-
Total 13F shares
-
50,544,840
-
Share change
-
+73,593
-
Total reported value
-
$1,208,003,010
-
Put/Call ratio
-
32%
-
Price per share
-
$23.90
-
Number of holders
-
231
-
Value change
-
-$370,491
-
Number of buys
-
113
-
Number of sells
-
109
Institutional Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q2 2025
As of 30 Jun 2025,
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) was held by
231 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,544,840 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, D. E. Shaw & Co., Inc., DIMENSIONAL FUND ADVISORS LP, Balyasny Asset Management L.P., STATE STREET CORP, Doma Perpetual Capital Management LLC, GOLDMAN SACHS GROUP INC, and AMERICAN CENTURY COMPANIES INC.
This page lists
231
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.